Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population

Digestive and Liver Disease

Volumn 35, Issue 8, 2003, Pages 571-576

  Neri, T M ^a   Cavestro, G M ^a   Seghini, P ^a   Zanelli, P F ^a   Zanetti, A ^a   Savi, M ^a   Podda, M ^b   Zuin, M ^b   Colombo, M ^b   Floreani, A ^c   Rosina, F ^d   Bianchi Porro, G ^e   Strazzabosco, M ^c   Okolicsanyi, Lajos ^a,c  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d GRADENIGO HOSPITAL   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

CFTR genes; Chronic cholestasis; HLA genes

Indexed keywords

GENOMIC DNA; HLA B ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; TRANSMEMBRANE CONDUCTANCE REGULATOR; TUMOR NECROSIS FACTOR ALPHA; CFTR PROTEIN, HUMAN; HLA DQ ANTIGEN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HAPLOTYPE; HLA MATCHING; HLA TYPING; HOMOZYGOSITY; HUMAN; INTRON; ITALY; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIMARY SCLEROSING CHOLANGITIS; STATISTICAL SIGNIFICANCE; CASE CONTROL STUDY; GENETICS; GENOTYPE; HOMOZYGOTE; MIDDLE AGED; POPULATION GENETICS; SCLEROSING CHOLANGITIS;

ADULT; CASE-CONTROL STUDIES; CHOLANGITIS, SCLEROSING; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENE FREQUENCY; GENETICS, POPULATION; GENOTYPE; HAPLOTYPES; HLA-B ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HOMOZYGOTE; HUMANS; ITALY; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2142752577     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(03)00274-3     Document Type: Article

References (50)

1. Chapman RWG, Arborgh BAM, Rhodes JM, Summerfield JA, Dick R, Sheuer PJ, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography and hepatic histology. Gut 1980;21:870-7.
2. LaRusso NF, Wiesner RH, Ludwig J, MacCarty RL. Primary sclerosing cholangitis. New Engl J Med 1984;310:899-903.
3. Ludwig J, LaRusso NF, Wiesner RH. The syndrome of primary sclerosing cholangitis. Prog Liver Dis 1990;9:555-66.
4. Lee YM, Kaplan MM. Primary sclerosing cholangitis. New Engl J Med 1995;332:924-33.
5. Martins EB, Chapman RWG. Sclerosing cholangitis. Curr Opin Gastroenterol 1995;11:452-6.
6. Okolicsanyi L, Fabris L, Viaggi S, Carulli N, Podda M, Ricci G, the Italian PSC study group. Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. Eur J Gastroenterol Hepatol 1996;8:685-691.
7. Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology 1999;30:325-36.
8. Helzeberg JH, Petersen JM, Boyer JL. Improved survival with primary sclerosing cholangitis: a review of clinicopathologic features and comparison of symptomatic and asymptomatic patients. Gastroenterology 1987;92:1869-75.
9. Aadland E, Schrumpf E, Fusa O, Elgjo K, Heilo A, Aakhus T, et al. Primary sclerosing cholangitis: a long term follow up study. Scand J Gastroenterol 1987;22:655-64.
10. Kim WR, Poterucha JJ, Wiesner RH, LaRusso NF, Lindor KD, Petz J, et al. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology 1999;29:1643-8.
11. Angulo P, Larson DR, Therneau TM, La Russo NF, Batts KP, Lindor KD. Time course of histological progression in primary sclerosing cholangitis. Am J Gastroenterol 1999;94:3310-3.
12. Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 2000;31:7-11.
13. de Groen PC. Cholangiocarcinoma in primary sclerosing cholangitis: who is at risk and how do we screen? Hepatology 2000;31:247-8.
14. Fusa O, Schrumpf E, Elgjo K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Semin Liver Dis 1991;11:31-9.
15. Okolicsanyi L, Cavestro GM, Spirli C, Strazzabosco M. Primary sclerosing cholangitis and inflammatory bowel disease: do infectious pathogens have any role. In: Guglietta A, Lirussi F, editors, Infectious pathogens in gastrointestinal and hepatic disorders, Barcelona: Prous Science; 1999, pp. 117-20.
16. Angulo P, Peter JB, Gershwin ME, DeSotel CK, Shoenfeld Y, Lindor KD. Serum autoantibodies in patients with sclerosing cholangitis. J Hepatol 2000;32:182-7.
17. Chapman RW, Varghese Z, Gaul R, Patel G, Kokinon N, Sherlock S. Association of primary sclerosing cholangitis with HLA-B8. Gut 1983;24:38-41.
18. Donaldson PT, Farrant JM, Wilkinson ML, Hayllar K, Portmann E, Williams R. Dual association of HLA DR2 and DR3 with primary cholangitis. Hepatology 1991;13:129-33.
19. Prochazka EJ, Terasaki PI, Park MS, Goldstein LI, Busuttil RW. Association of primary sclerosing cholangitis with HLA-DRw52a. New Engl J Med 1990;322:1842-4.
20. Olerup O, Broomè U, Einarsson K, Zetterrsquist H. Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid position of the HLA-DRw52a allele. New Engl J Med 1991;325:1251-2.
21. Mehal WZ, Wordsworth BP, Taylor CJ, Bell JI, Fleming KA, Chapman RW. Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid position of the HLA-DRw52a allele. New Engl J Med 1991;325:1252.
22. Zetterquist H, Broomè U, Einarsson K, Olerup O. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with primary sclerosing cholangitis. Gut 1992;33:942-6.
23. Mehal WZ, Lo Y, Wordsworth BP, Neuberger JM, Hubscher SC, Fleming KA, et al. HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1994;106:160-7.
24. Olerup O, Olsson R, Hultcranz R, Broomè U. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis. Gastroenterology 1995;108:870-8.
25. Farrant JM, Doherty DG, Donaldson PT, Vaughan RW, Hayllar KM, Welsh KI, et al. Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis. Hepatology 1992;16:390-5.
26. Bernal W, Moloney M, Underhill J, Donaldson PT. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis. J Hepatol 1999;30:237-41.
27. Mitchell S, Grove J, Spurkland A, Boberg KM, Fleming KA, DaY CP, et al. Association of the tumor necrosis factor a-308 but not the interleukin 10-627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut 2001;49:288-94.
28. Spurkland A, Saarinen S, Boberg KM, Mitchell S, Broomè U, Caballeria L, et al. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens 1999;53:459-69.
29. Norris S, Kondeatis E, Collins R, Satsangi J, Clare M, Chapman R, et al. Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism. Gastroenterology 2001;120:1475-82.
30. Wiencke K, Spurkland A, Schrumpf E, Boberg KM. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles. Hepatology 2001;34:625-30.
31. Escorsell A, Pares A, Rodes J, Solis-Herruzo JA, Miras M, de la Morena E. Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver. J Hepatol 1994;21:787-91.
32. Okolicsanyi L, Fabris L. Diagnostic approach to primary sclerosing cholangitis: open questions. Ital J Gastroenterol 1991;23:436-41.
33. McGill JM, Williams DM, Hunt CM. Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis. Dig Dis Sci 1996;41:540-2.
34. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumor necrosis factor alpha (TNF α) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353.
35. Brinson EC, Adriano T, Bloch W, Brown CL, Chang CC, Chen JG, et al. Introduction to PCR/OLA/SCS, a multiplex DNA test, and its application to cystic fibrosis. Genet Test 1997;1:61-8.
36. Svejaard A, Ryder LP. HLA and disease associations. Detecting the strongest association. Tissue Antigens 1994;43:18-27.
37. Armitage P. Statistical methods in medical research, Italian ed. Milan: G. Feltrinelli; 1975.
38. Bergstrom TF, Josefsson A, Erlich HA, Gyllensten U. Recent origin of HLA-DRB1 alleles and implications for human evolution. Nat Genet 1998;18:237-42.
39. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996;273:1516-7.
40. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994;265:2037-48.
41. Rendine S, Borelli I, Barbanti M, Sacchi N, Roggero S, Curtoni ES. HLA polymorphism in Italian bone marrow donors: a regional analysis. Tissue Antigens 1998;52:135-46.
42. Salvarani C, Macchioni PL, Mantovani W, Bragliani M, Collina E, Cremonesi T, et al. HLA-DRB1 alleles associated with rheumatoid arthritis in Northern Italy: correlation with disease severity. Br J Rheumatol 1998;37:165-9.
43. Boberg KM. Prevalence and epidemiology of autoimmune hepatitis. Clin Liver Dis 2002;6:347-59.
44. Galeazzi M, Sebastiani GD, Morozzi G, Carcassi C, Ferrara GB, Scorza R, et al. HLA Class II DNA typing in a large series of European Patients with Systemic Lupus Erythematosus. Medicine (Baltimore) 2002;81:169-78.
45. Petrone A, Giorgi G, Mesturino CA, Capizzi M, Cascino I, Nistico L, et al. Association of DRB1*04-DQB1*03 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid 2001;11:171-5.
46. Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, et al. Autoimmune hepatitis / sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study. Hepatology 2001;33:544-53.
47. Strazzabosco M. Transport systems in cholangiocytes: their role in bile formation and cholestasis. Yale J Biol Med 1997;70:427-34.
48. Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. New Engl J Med 1998;339:645-52.
49. Cohn JA, Friedman KJ, Noone PG, Knowles MR, Silverman LM, Jowell PS. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. New Engl J Med 1998;339:653-8.
50. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;52:506-13.